Many studies have shown that PPAR gamma activation can hinder the progress of lung cancer, and PPARG ligand can be used as a potential therapeutic agent for lung adenocarcinoma and PPARG can also effectively treat lung squamous cell carcinoma.45 This evidence concerns the gene PPARG and lung carcinoma.